ProPhase Labs (PRPH) News Today → Biden replacement revealed? (From Paradigm Press) (Ad) Free PRPH Stock Alerts $4.95 -0.11 (-2.17%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024globenewswire.com - April 25 at 8:00 AMDiamond Equity Equities Analysts Cut Earnings Estimates for ProPhase Labs, Inc. (NASDAQ:PRPH)marketbeat.com - April 25 at 7:37 AMProPhase Labs, Inc. (NASDAQ:PRPH) to Post Q1 2025 Earnings of $0.10 Per Share, Diamond Equity Forecastsamericanbankingnews.com - April 25 at 2:21 AMEquities Analysts Set Expectations for ProPhase Labs, Inc.'s Q1 2025 Earnings (NASDAQ:PRPH)marketbeat.com - April 24 at 6:32 AMProPhase Labs (NASDAQ:PRPH) Stock Price Crosses Above Two Hundred Day Moving Average of $5.00americanbankingnews.com - April 23 at 4:44 AMProPhase Labs Shares Jump on New AI-Based Projectmarketwatch.com - April 16 at 3:52 PMProPhase Labs Unveils Project ZenQ-AIglobenewswire.com - April 16 at 8:00 AMProPhase Labs, Inc.: ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024finanznachrichten.de - April 10 at 10:26 AMProPhase Flat on Cancer Drug Progressbaystreet.ca - April 10 at 10:26 AMProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024globenewswire.com - April 10 at 8:00 AMProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)globenewswire.com - April 1 at 9:00 PMProPhase Labs, Inc. (PRPH)finance.yahoo.com - April 1 at 1:09 AMShort Interest in ProPhase Labs, Inc. (NASDAQ:PRPH) Declines By 16.9%marketbeat.com - March 30 at 9:21 AMProPhase Labs (NASDAQ:PRPH) Stock Price Crosses Above 200-Day Moving Average of $4.77marketbeat.com - March 29 at 3:21 AMProPhase Labs, Inc. (NASDAQ:PRPH) Expected to Earn Q1 2024 Earnings of ($0.41) Per Sharemarketbeat.com - March 21 at 8:02 AMProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 18 at 9:29 AMPRPH Stock Earnings: ProPhase Labs Misses EPS, Misses Revenue for Q4 2023msn.com - March 15 at 1:48 PMProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic Initiativesglobenewswire.com - March 15 at 8:00 AMProPhase Labs's Earnings: A Previewbenzinga.com - March 14 at 2:34 PMDown 34% and 57%, Wall Street Says These 2 Stocks Will Gain 230%msn.com - March 12 at 7:21 PMProPhase Labs (PRPH) Scheduled to Post Earnings on Fridaymarketbeat.com - March 9 at 8:26 AMPROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024globenewswire.com - March 8 at 8:00 AMProPhase Labs, Inc. (NASDAQ:PRPH) Shares Could Be 29% Above Their Intrinsic Value Estimatefinance.yahoo.com - March 1 at 8:32 AMHighTower Advisors LLC Takes $756,000 Position in ProPhase Labs, Inc. (NASDAQ:PRPH)marketbeat.com - February 28 at 4:26 AMAnalysts Offer Insights on Healthcare Companies: Prophase Labs (PRPH) and Crispr Therapeutics AG (CRSP)markets.businessinsider.com - February 21 at 5:30 PMDiamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH)finance.yahoo.com - February 21 at 12:27 PMProPhase Labs Announces Significant Progress in BE-Smart Esophageal Cancer Test Development USPTO grants additional broad patents for BE-SMARTfinance.yahoo.com - February 20 at 9:05 AMProPhase Labs Announces Significant Progress in BE-Smart Esophageal Cancer Test Development USPTO grants additional broad patents for BE-SMARTfinance.yahoo.com - February 20 at 9:05 AMProPhase Labs (NASDAQ:PRPH) Stock Passes Above Two Hundred Day Moving Average of $4.87marketbeat.com - February 17 at 3:50 AMPRPH Mar 2024 5.000 putfinance.yahoo.com - February 16 at 10:42 PMBuy Rating for Prophase Labs on Strong Clinical Trial Results and Manufacturing Expansionmarkets.businessinsider.com - February 15 at 10:51 AMProPhase Labs, Inc.: ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivirfinanznachrichten.de - February 14 at 1:22 PMProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivirfinance.yahoo.com - February 14 at 8:22 AMProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivirglobenewswire.com - February 14 at 8:00 AMProPhase Labs (NASDAQ:PRPH) Share Price Crosses Above Two Hundred Day Moving Average of $4.94marketbeat.com - February 9 at 3:48 AMDiamond Equity Research Releases In Depth Update Note on ProPhase Labs, Inc. (NASDAQ: PRPH) subsidiary, Pharmaloz Manufacturing, Inc. (PMI)finance.yahoo.com - February 8 at 8:14 AMProPhase Dips on Moving Karkus up Ladderbaystreet.ca - January 30 at 2:51 PMProPhase Labs Ushers in New Genomics Era with Jason Karkus at the Helm of Nebula Genomicsfinance.yahoo.com - January 30 at 9:50 AMProPhase Labs, Inc.: Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New Contractsfinanznachrichten.de - January 23 at 1:04 PMPharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New Contractsfinance.yahoo.com - January 23 at 1:04 PMProPhase Labs Inc (PRPH)uk.investing.com - January 13 at 11:24 PMAclaris posts topline data from mid-stage trial for eczema therapymsn.com - January 10 at 10:18 AMProPhase hires Jed Latkin as COOmsn.com - January 4 at 2:02 PMProPhase poised to ramp up growth at Pharmaloz and Nebula Genomics in 2024finance.yahoo.com - January 4 at 9:01 AMProPhase Labs Stock (NASDAQ:PRPH) Dividends: History, Yield and Datesbenzinga.com - December 30 at 10:12 AMmarketbeat.com - November 30 at 9:31 AMProPhase Labs Stock (NASDAQ:PRPH), Analyst Ratings, Price Targets, Predictionsbenzinga.com - November 12 at 1:48 PMSHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of ProPhase Labs, Inc. (NASDAQ: PRPH) and Encourages Investors to Contact the Firmbenzinga.com - November 11 at 12:21 PMProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 10 at 4:18 PMProPhase Labs reports Q3 resultsmsn.com - November 9 at 3:13 PM Get ProPhase Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for PRPH and its competitors with MarketBeat's FREE daily newsletter. Email Address It’s now possible to know the win rate of every trade… BEFORE you take it! (Ad)Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets. >> You can grab your FREE, laminated copies right here << PRPH Media Mentions By Week PRPH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRPH News Sentiment▼1.460.41▲Average Medical News Sentiment PRPH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRPH Articles This Week▼81▲PRPH Articles Average Week Get ProPhase Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for PRPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: GTH News Today LPTX News Today ENZ News Today OMGA News Today AGEN News Today SGMT News Today CPSI News Today FTLF News Today ZURA News Today RZLT News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PRPH) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProPhase Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
